UBS Group’s Salarius Pharmaceuticals SLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.3K Sell
1,209
-1,045
-46% -$14K ﹤0.01% 7263
2025
Q1
$25.5K Buy
2,254
+1,782
+378% +$20.2K ﹤0.01% 6756
2024
Q4
$13K Buy
472
+455
+2,676% +$12.6K ﹤0.01% 6933
2024
Q3
$375 Buy
17
+9
+113% +$199 ﹤0.01% 7753
2024
Q2
$269 Buy
+8
New +$269 ﹤0.01% 7854
2024
Q1
Sell
-1
Closed -$51 7925
2023
Q4
$51 Hold
1
﹤0.01% 7777
2023
Q3
$51 Hold
1
﹤0.01% 7850
2023
Q2
$116 Sell
1
-8
-89% -$928 ﹤0.01% 7399
2023
Q1
$2.15K Buy
9
+7
+350% +$1.67K ﹤0.01% 7465
2022
Q4
$366 Sell
2
-12
-86% -$2.2K ﹤0.01% 9021
2022
Q3
$8K Hold
14
﹤0.01% 7645
2022
Q2
$9K Buy
14
+13
+1,300% +$8.36K ﹤0.01% 7127
2022
Q1
$1K Hold
1
﹤0.01% 8861
2021
Q4
$1K Sell
1
-1
-50% -$1K ﹤0.01% 8899
2021
Q3
$7K Hold
2
﹤0.01% 7178
2021
Q2
$7K Sell
2
-2
-50% -$7K ﹤0.01% 7244
2021
Q1
$19K Buy
+4
New +$19K ﹤0.01% 6423
2020
Q2
Sell
-4
Closed -$8K 7291
2020
Q1
$8K Buy
+4
New +$8K ﹤0.01% 6172
2019
Q4
Sell
-1
Closed -$17K 6682
2019
Q3
$17K Buy
+1
New +$17K ﹤0.01% 5872
2019
Q2
Hold
0
7125
2019
Q1
Sell
-1
Closed -$13K 7090
2018
Q4
$13K Buy
+1
New +$13K ﹤0.01% 6178
2018
Q3
Hold
0
-$1K 7161
2018
Q2
Hold
0
6900
2018
Q1
Hold
0
-$7K 7048
2017
Q4
Hold
0
-$6K 6264
2017
Q3
Hold
0
-$13K 6235
2017
Q2
Hold
0
-$18K 5662
2017
Q1
Hold
0
-$9K 5298
2016
Q4
Hold
0
6025
2016
Q3
Hold
0
-$21K 6828
2016
Q2
Hold
0
5392
2016
Q1
Hold
0
-$17K 6845
2015
Q4
Hold
0
-$30K 5686
2015
Q3
Hold
0
5103
2015
Q2
Hold
0
-$24K 6867
2015
Q1
Hold
0
5241